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Microenvironmental cooperation 
promotes early spread and 
bistability of a Warburg-like 
phenotype
Jorge Fernandez-de-Cossio-Diaz1, Andrea De Martino2,3 & Roberto Mulet4
We introduce an in silico model for the initial spread of an aberrant phenotype with Warburg-like 
overflow metabolism within a healthy homeostatic tissue in contact with a nutrient reservoir (the 
blood), aimed at characterizing the role of the microenvironment for aberrant growth. Accounting for 
cellular metabolic activity, competition for nutrients, spatial diffusion and their feedbacks on aberrant 
replication and death rates, we obtain a phase portrait where distinct asymptotic whole-tissue states 
are found upon varying the tissue-blood turnover rate and the level of blood-borne primary nutrient. 
Over a broad range of parameters, the spreading dynamics is bistable as random fluctuations can 
impact the final state of the tissue. Such a behaviour turns out to be linked to the re-cycling of overflow 
products by non-aberrant cells. Quantitative insight on the overall emerging picture is provided by a 
spatially homogeneous version of the model.
Overflow metabolism, namely the incomplete oxidation of nutrients at high intake rates leading to the secretion 
of partially metabolized products, is ubiquitous in cellular systems. Fast growth or high rates of energy expend-
iture are accompanied by the excretion of carbon equivalents like acetate in E. coli1, ethanol in yeast2, lactic acid 
in skeletal muscle cells3, and lactate in many types of tumors4 (where this is known as the Warburg effect). A 
similar scenario has been observed in immune cells5. Many studies have addressed the functional role6 as well as 
the origin of this kind of metabolic re-programming at different levels, focusing most recently on the constraints 
on cellular energy metabolism imposed by different metabolic demands7–9, macromolecular crowding10, costs 
associated to gene expression11–13, membrane occupancy14 or intrinsic limits to mitochondrial oxidative phospho-
rylation15, as well as on hypoxia16 and dynamical mechanisms like flux sensors17 (see refs 18, 19 for recent reviews 
of different models and possible mechanisms).
The effects of overflow in cell populations, however, specifically for the creation of functionally relevant 
microenvironments, are less studied. While it has been argued that the competition between slow-growing 
oxidizers and fast-growing fermenters may have played a central role in the evolution of multicellularity20, 21, 
empirical evidence suggests that an effective cooperation between these distinct phenotypes may arise from the 
competition for nutrients, with important physiological consequences. The simplest manifestation of such a 
regime is via the shuttling of overflow products22. In short, fast growing cells typically outcompete their quiescent 
neighbours for the primary carbon source. In such conditions, the latter may have to re-adjust their metabo-
lism, ultimately relying on the carbon equivalents excreted by the former for survival. This kind of cell-to-cell 
coupling has been found to play an important role in multicellular contexts ranging from cancer23 to muscle 
cells24 to brain energy metabolism25, 26. In cancer, the lactate-shuttle scenario has been analyzed theoretically27 
and in silico28, experimentally through indirect genetic evidence23, and has also been discussed as a potential 
therapeutic target29 in the recent revival of interest in the re-programming of metabolism in cancer30 (but see also 
ref. 31). Taken together with the growing literature on tumor-stroma interactions32, 33, these results present can-
cer as a strongly non-cell-autonomous disease and suggest a major functional role for the cooperative coupling 
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between overflowing and non-overflowing cells. Similar scenarios have been studied in the context of microbial 
populations34–36.
Besides strictly energetic considerations related to the usefulness of overflow products (like lactate, acetate, 
ethanol and ammonia) as metabolic fuels, their shuttling might serve the added purpose of clearing the extracel-
lular space of the potentially toxic side-effects caused by their accumulation. The toxicity of lactate and ammonia 
has been well characterized for mammalian cell cultures37, 38 and cancer39, 40, in which case the increased microen-
vironment acidity caused by extracellular lactate has been found to stimulate the death of surrounding cells41, 42. 
In turn, acetate can inhibit E. coli growth by as much as 50%1, 43 while yeast’s tolerance to ethanol is known to be 
strongly strain-dependent44. Likewise, industrial mammalian cell cultures are commonly affected by the accu-
mulation of toxic metabolites secreted during the production process and exhibit qualitatively distinct metabolic 
states in response to variations in extracellular metabolite concentrations, transitioning from efficient, oxidative 
phenotypes to inefficient wasteful states45. In this context the accumulation of waste is usually undesired and one 
strives to maintain cells that can fully metabolize their nutrients into compounds of interest, posing an important 
biotechnological challenge46.
Here we attempt to study in silico how carbon overflow affects the overall metabolic organization of cells in a 
tissue, including spatial effects as well as effects due to shuttling, microenvironment toxification and exchanges 
with the blood. Our scenario is close to that considered in models of avascular tumor growth47–49 but integrates 
a coarse-grained perspective of cell metabolism along the lines of refs 28, 50 and the acidification of the environ-
ment due to the byproducts of metabolism. In particular, we assume that, in a tissue formed by healthy cells which 
can exchange compounds with a chemical reservoir, a single aberrant cell is planted, with upregulated primary 
nutrient transporters and disregulated energetics leading to carbon overflow and (stochastically) aberrant cell 
death and/or replication. We analyze the conditions under which the competition for the primary carbon source 
can be turned into a cooperative regime where non-aberrant cells are sustained by the aberrant ones’ overflow 
product, in turn fostering the spread of the latter. By extensive numerical simulations, we obtain a “phase struc-
ture” in which the outcome is studied as a function of the concentration c of primary nutrient in the reservoir and 
of the characteristic turn-over rate k for tissue-reservoir exchanges. We furthermore develop a mathematically 
solvable version of the model where spatial effects are neglected, allowing to unveil the physical origin of many of 
the key features found in its spatial counterpart. Our results suggest that the accumulation of waste can limit the 
growth of the aberrant cells, leading to their demise, unless remediated either by re-cycling via healthy cells or by 
export away from the tissue. In such a scenario, c and k are the key variables controlling whether the aberrant cells 
will spread to the entire tissue. However, in the spatial model, random fluctuations can drive the tissue toward 
different outcomes. This bistability is absent in the spatially homogeneous version and is tightly coupled to the 
shuttling of overflow products.
Results
Model definition and properties. Basic setup. We consider an ensemble of cells (a “tissue” for short) in 
contact with a nutrient reservoir (the “blood”, see Fig. 1A). The tissue is modeled as a single layer of cells arranged 
in an N × N square lattice, with each site i occupied by a cell. A primary carbon source S (say, glucose) is available 
in the blood at a fixed concentration denoted by c, and can diffuse through the blood-tissue barrier and across 
the tissue. Likewise, a waste product of the metabolism of cells within the tissue can diffuse across the tissue or be 
exported into the blood. The effect of metabolite exchange with the blood is quantified by an effective metabolite 
turn-over time τ.
Cellular metabolic networks. Cells can be of two types, which we shall call “healthy” and “aberrant” respectively. 
The two types differ slightly in their metabolic capabilities. Specifically, each cell i can import and process S at a 
rate ui that depends on the local substrate level si and on its energy demand (see Fig. 1B). The in-taken nutrient is 
processed into a partially metabolized precursor P and energy E (i.e. ATP), with a theoretical energy yield equal 
to Yu (i.e. at most Yu units of energy are obtained per unit of ui). However, while aberrant cells can turn P into a 
‘waste’ metabolite W and excrete it, healthy cells can import W and re-cycle it to produce P. The corresponding 
fluxes vi (vi ≥ 0 for importing healthy cells, vi ≤ 0 for exporting aberrant cells) are determined by the local level 
of W in the tissue (denoted by wi) and by cellular energy demands. Finally, energy can be derived from P at rate 
ri given, by mass-balance, by ri = ui + vi ≥ 0. Assuming a yield for the P → E conversion equal to Yr, the energy 
output flux obtainable from S and W is
= + ≡ + + .e Y u Y r Y u Y u v( ) (1)i u i r i u i r i i
Identifying ri with the flux through respiration, we assume it is capped50 so that 0 ≤ ri ≤ rmax. We furthermore 
assume that Yu < Yr, by analogy with the universally lower yield of fermentation versus respiration.
Metabolic objectives and optimal flux patterns. Aberrant and healthy cells also differ strongly both in their max-
imum S-intake capability, with aberrant cells assumed to be able to sustain much higher values of ui than healthy 
cells, and in their respective metabolic goals, in that the former are assumed to maximize their energy output (1) 
while the latter only aim at generating a fixed maintenance energy output flux em. In addition, we conform to 
empirical in vitro studies showing that cells may consume a waste product of their metabolism like lactate or 
acetate only after glucose is depleted46, 51, and assume that cells employ the primary nutrient preferentially. These 
assumptions lead to specific forms for the key fluxes ui and vi. Defining = +u s u s K s( ) /( )i i iMM max s  and 
= +v w v w K w( ) /( )i i iMM max w  as the fluxes of standard Michaelis-Menten uptake kinetics with parameters (umax, 
Ks) and (vmax, Kw), and denoting by ≡ +u e Y Y/( )m m u r  the smallest value of ui ensuring that ei = em without resort-
ing to W (i.e. for vi = 0) one has that, for healthy cells,
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whereas for aberrant cells
α=u u s( ) (4)i iab MM
= −v r umin{0, } (5)i imax
with α  1ab  a constant quantifying the dysregulated uptake capacity of aberrant cells. In words, for healthy cells, 
if uMM(si) > um then ui = um and no in-take of W is required to ensure that ei = em (i.e. vi = 0). On the other hand, 
for uMM(si) < um cells will import as much of S as possible and then import either the minimal amount of W 
required to meet their energy demand = − +( )( )v u u( ) 1i m i YYur  or as much W as possible according to local 
availability (vi = vMM(wi)). For aberrant cells, instead, if ui < rmax then all the primary nutrient imported can be 
processed through ri and no precursor is excreted (vi = 0). When ui exceeds rmax, though, W is produced and 
secreted at net rate |vi| = ui − rmax.
Aberrant cells death and replication dynamics. A feedback between the population dynamics of aberrant cells 
and waste accumulation in the tissue is established by the fact that both their replication (λi) and death (σi) rates 
depend on the local level of waste wi (see Fig. 1C). In particular, we assume that every aberrant cell with at least 
Figure 1. Scheme of main processes considered in the model. (A) A single layer of cells arranged in an N × N 
square lattice (the “tissue”) is in contact with a reservoir (the “blood”), where a primary carbon source S is 
available at concentration c. S can diffuse through the blood-tissue barrier and inside the tissue. Each tissue site 
is occupied by a cell that can be either “healthy” or “aberrant”. (B) Each cell can import and process S generating 
energy E (rate u, yield Yu) and a precursor P and further process the precursor into E (rate r, yield Yr > Yu). 
Because r is capped, aberrant cells can process the excess precursor into a waste product W, which is excreted 
and can diffuse across the tissue and into the blood. Healthy cells instead operate far from saturating r and can 
re-cycle W to generate more P. (C) Aberrant cells have a larger capacity to import S and aim at maximizing their 
energy output flux e. em instead represents the maintenance energy output of healthy cells. Cells are sensitive to 
the local concentrations of W (denoted by w) and S (denoted by s). In particular, aberrant cells replicate at a rate 
λ that is an increasing function of their energy output and a decreasing function of w. Likewise, they can die 
(and be replaced by a healthy cell) at a rate σ that is an increasing function of w. The primary nutrient import 
flux is instead a function of the local level of S experienced by cells.
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one healthy neighbor can replicate, with the daughter cell occupying the site of a randomly picked normal neigh-
bor, with a probability per unit time given by
λ λ=
−
− + +
e e
e e K
K
K w
max{ , 0} ,
(6)i
i m
i m i
max
E
inh
inh
where λmax represents the fastest growth rate achievable by aberrant cells while Kinh and KE are constants. In short, 
the growth rate is zero unless cells exceed the maintenance energy flux em, it increases in a Monod fashion as ei 
grows, but gets smaller as wi increases52. The particular choice for the dependence on wi avoids the introduction 
of extra parameters (compared for instance to a Hill function) while returning the same qualitative behaviour. 
Likewise, we assume the death rate σi to be given by refs 53, 54
σ σ=
+
w
K w
,
(7)i
i
i
max
tox
which becomes larger (and tends to the limiting value σmax) as wi increases. We assume that aberrant cells are 
replaced by healthy ones upon dying. Note that we don’t consider a specific birth/death dynamics for healthy cells, 
implicitly assuming that they are found in all tissue sites that are not occupied by aberrant cells (e.g. both aberrant 
and healthy cells are immediately replaced by healthy ones at death). In such conditions, the growth dynamics of 
healthy cells is immaterial.
Diffusion of primary nutrient and waste. Finally, the local concentrations of the primary nutrient (si) and of the 
precursor (wi) are assumed to change in time and space according to
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where τ≡k 1/ . The first terms on the right-hand-sides of (8, 9) represent the local concentration smoothing due 
to diffusion, with DS and DW the diffusion coefficients, d the number of neighbors of cell i (d = 4 in our case) and 
the sum runs over the set i( )  of neighbors of cell i. The second terms describe the changes due to import or 
export of compounds by cells, with ui and vi depending on concentrations as discussed in (2), (3), (4) and (5). The 
third terms denote instead the variations due to the exchange of primary nutrient and, respectively, the removal 
of the precursor from the tissue, in which the blood acts as an external reservoir for S and as a sink for W.
Time evolution. After initiating the system in a configuration with a single aberrant cell among healthy cells 
(time t = 0), the dynamics of aberrance spread depends on (i) the pattern of local availability of primary nutrient, 
and (ii) how efficiently growth-suppressing waste can be removed from the tissue, either via the blood or via recy-
cling by healthy cells. Overall, this scenario describes the conditions for the emergence of a mutually beneficial 
(local) microenvironment, characterized by a W-mediated metabolic coupling between healthy and aberrant 
cells. We are interested in quantifying its role in the sustainment of aberrant growth and the survival of healthy 
cells, and in understanding how it relates to the macroscopic environmental parameters c (the concentration of 
primary nutrient in the blood) and τ = k−1 (metabolite turn-over time).
Dynamics of aberrant spread. We carried out extensive numerical simulations of the model upon chang-
ing the key environmental parameters c and k, after having rendered parameters non-dimensional and having set 
them at realistic representative values (see Methods). Typical snapshots from a full-scale simulation of a 20 × 20 
tissue obtained for k = 103 and c = 0.1 are shown in Fig. 2A. Initially, the aberrance spreads and waste is secreted 
(red markers, v < 0), while nearby healthy cells are deprived of primary nutrient and start to rely on the waste 
secreted by aberrant cells for survival (pink markers, v > 0). Growth of the aberrant population is therefore sus-
tained by the coupling with healthy cells. Eventually, though, the primary nutrient gets depleted and aberrant cells 
in the core no longer saturate the respiration flux (black markers, v = 0), thereby ceasing waste secretion.
Figure 2B,C summarize the main features of the time evolution of the system observed in the simulation. The 
mean local concentration of primary nutrient s decreases with time while the average waste level w increases 
rapidly until it peaks (black arrow). At that point, healthy cells begin to in-take and recycle the waste product of 
aberrant growth for survival when their maintenance demands cannot be met from the primary nutrient alone 
(see Fig. 2C). A noticeable acceleration in aberrant growth then occurs (viz. the change in slope at the black 
dashed line in Fig. 2B) as the waste concentration begins to decrease and the environment becomes less toxic. As 
s decreases, W becomes the main metabolic fuel of healthy cells, while a fraction of aberrant cells in the core stops 
secreting W, further pushing down the level of waste. At the peak of waste uptake by healthy cells (green arrow), 
a second inflection point in aberrant growth can be observed (viz. the slope change at the green dashed line in 
Fig. 2B). The mean waste level vanishes shortly thereafter. Eventually the entire tissue is taken over by aberrant 
cells and φ saturates at one.
Phase portrait. Results concerning dynamical features and final configurations can be summarized in the 
‘phase portrait’ displayed in Fig. 3A in terms of the asymptotic value of the mean fraction φ of aberrant cells in the 
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tissue as a function of c and of the effective blood-tissue turn-over rate k (averages over 20 runs). At low nutrient 
level and long turnover times (region labeled W−), the primary source cannot support aberrant growth and the 
tissue ultimately stays healthy. In this region, no waste accumulates in the tissue and therefore no waste recycling 
occurs. Upon increasing k and/or c (region labeled Sh.), one enters a phase in which metabolic coupling with 
waste recycling occurs during the dynamics. Interestingly, though, if k gets sufficiently large, the aberrance can 
spread to the whole tissue, strongly implicating the metabolic coupling and/or enhanced remediation through the 
bloodstream as keys for tissue takeover by aberrant cells. A third regime (region labeled W+) occurs if k or c are 
sufficiently large, in which healthy cells can meet their energy demand thanks to the large availability of primary 
substrate, so that no recycling takes place. If the increase in c is not coupled to an increase in k, waste accumulates 
in the tissue because blood exchange alone does not suffice to remove W (k too low), thereby repressing aberrant 
growth due to increasing toxicity. As a consequence, the tissue stays healthy in the long run. On the other hand, 
if k also increases, aberrant cells ultimately take over the tissue as the growth-suppressing waste product is effi-
ciently cleared from the tissue thanks to the high turn-over rate.
Figure 2. Simulation results for the case of fast turn-over rate (large k) and low blood nutrient level (small c). 
(A) Snapshots of the tissue. Aberrant growth is sustained by the waste-mediated coupling with healthy cells, 
which re-cycle W to survive, thereby allowing for a fast replication rate of aberrant cells. Where no re-cycling 
occurs, aberrant cells no longer excrete W but cease to grow. Time is in units of the inverse death rate (see 
Methods). (B) Fraction of aberrant cells (φ), mean tissue level of primary nutrient (s) and mean tissue level of 
waste (w) as a function of time. (C) Mean primary nutrient intake flux (uhe) and mean waste intake flux (vhe) 
by healthy cells. The curves in (B,C) are normalized to a maximum of 1. The arrows in (B,C) mark significant 
points of inflection in the growth of aberrant cells, discussed in the text.
Figure 3. Phase portrait of the spatial model in the space spanned by the blood-tissue turn-over rate k and 
nutrient availability c. Asymptotic value of the fraction φ of aberrant cells (color coded) as a function of the 
turn-over rate τ≡ −k 1 and of the level c of primary nutrient in the blood. Dashed red lines delimit regions with 
qualitatively different roles for the waste. In region labeled W− no waste is secreted; in region Sh., waste 
secretion by aberrant cells occurs coupled with waste recycling by healthy cells; in region W+, waste secretion 
but no re-cycling takes place. Simulations are carried out in a 20 × 20 grid, and results are averaged over 20 
different runs per point. The yellow dot marks the parameters used in Fig. 2.
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Insights from a solvable mathematical model. Spatially homogeneous model. The origin of the rich 
behavior observed in silico can be mathematically traced by a simplified, analytically tractable version of the 
model. The simplification consists in assuming spatial homogeneity, i.e. that the transport and diffusion of the pri-
mary substrate S and of the waste product W are sufficiently fast for all cells to sense the same local levels of both 
species. This leads to a “mean-field” type of model that ignores the spatial organization of cells. The state of the tis-
sue can be fully described in terms of three variables, namely the fraction of aberrant cells φ, the level of primary 
nutrient in tissue s and the level of waste product in tissue w. Assuming that the daughters of aberrant cells replace 
normal cells in a population constrained to a fixed total size, the above quantities evolve in time according to
φ λ σ φ φ= − −
t
d
d
( ) (1 ) (10)
φ φ= − − − + −s
t
u u k c sd
d
(1 ) ( ) (11)ab he
φ φ= − − − −w
t
v v kwd
d
(1 ) (12)ab he
where the parameters λ (replication rate of aberrant cells), σ (death rate of aberrant cells), uhe and uab (primary 
nutrient intake flux of a healthy and, respectively, aberrant cell), and vhe and vab (the waste intake and, respectively, 
out-take flux of a healthy and, respectively, aberrant cell) depend in turn on s and w as in Equations (2)–(7). 
Equation (10) describes the change in φ due to duplication and death events (both of which require the vicinity of 
a healthy cell) at fixed total number of cells. The evolution of s and w, instead, is due to cellular import and export 
activities and to exchanges with the blood.
Coupling fast homogenization with a quasi-steady-state assumption for concentration variables (based on the 
fact that the time scales characterizing cell replication are much longer than those over which tissue levels of 
primary nutrient and waste equilibrate) allows to decouple the dynamics of s and w from that of φ. Specifically, 
setting = = 0ds
dt
dw
dt
, one may express both quantities as functions of φ, thereby leaving the latter as the key vari-
able of the model. Numerical solution of its equilibrium value from Eq. (10) (see Methods for the choice of 
parameters) finally results in the phase portrait displayed in Fig. 4A. The homogeneous model appears to match 
closely its spatial counterpart (Fig. 3) except for a key detail, provided in Fig. 4B. In specific, one sees that the 
spatial model displays coexistence of fully aberrant states with fully healthy states for low k and intermediate c 
(region Sh.), i.e. for the same values of c and k different runs may end up with the tissue being taken over by aber-
rant cells or with a completely healthy tissue, while the simplified model is unable to capture this aspect.
Cutting through the (k, c) diagram at different levels of c (displayed as yellow lines in Fig. 4A) different scenar-
ios are highlighted (see Fig. 4C). For low c, φ gradually increases with k until it saturates close to the maximum. 
Upon further increasing k, one generates a waste shuttling from aberrant to healthy cells with accumulation 
of waste in the tissue, which is remediated at higher k by faster wash-away into the blood stream. At high c, 
instead, aberrant cells can survive even at low k without secreting waste. If k increases, though, waste excre-
tion sets in that is not managed since (i) the local level of primary nutrient is large enough for healthy cells to 
survive based on it alone, and (ii) removal by the blood is still too slow. As a consequence, aberrant growth is 
repressed and φ decreases. A further increase of k however allows to re-start aberrant growth by clearing up the 
micro-environment.
The state of the tissue is regulated by a series of thresholds. It is remarkable that the transition between full aber-
rant dominance and healthy tissue in some cases turns out to be discontinuous, viz. the separation between the 
Sh. and W+ regions marked by a blue line in Fig. 4A and by a blue arrow in Fig. 4C. In such conditions, small 
variations in k or c suffice to cause large-scale changes in the final tissue state. The same behaviour is observed in 
the fully spatial model (cf. Fig. 4B). This highlights the existence of thresholds where the qualitative characteris-
tics of aberrant growth and tissue metabolism change drastically. Within the solvable model, it is possible to fully 
trace their origin to the parameters of the model. Mathematical analysis (see Supporting Text) leads in particular 
to the identification of three thresholds for the tissue level of primary substrate, i.e.
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using which the phase structure can be understood. Note that we assume um ≤ rmax (see Methods), so that 
sgr ≤ ssec ≤ sm.
Starting from (13), healthy cells are found to be able to sustain their maintenance demands from the primary 
nutrient alone if s ≥ sm, while for s < sm they must rely on re-cycling of W (if available). Aberrant cells, on the other 
hand, can have a non-zero replication rate (Eq. 6) if s > sgr and they secrete W if s > ssec. Therefore, a metabolic 
coupling with shuttling of W from aberrant to healthy cells may only exist in the range ssec < s < sm. (In turn, 
sm > ssec or, equivalently, rmax < αabum is a necessary condition for metabolic coupling).
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In terms of the fraction of aberrant cells, instead, the thresholds (14) simply represent the values of φ that are 
consistent with the corresponding quasi-steady state nutrient level. So, for instance, the growth rate of aberrant cells 
is zero when φ ≥ φgr, implying that φgr is an upper bound for the fraction of aberrant cells in the system. On the 
other hand φm is the maximum fraction of aberrant cells consistent with healthy cells satisfying their maintenance 
demands from the consumption of primary nutrient alone, while waste secretion occurs if φ < φsec. Therefore, a 
waste shuttle takes place when φm < φ < φsec. The thresholds (14) are shown in Fig. 5B as functions of k and c.
Physical origin of the different phases. Comparing the asymptotic aberrant fraction φf to the thresholds Eq. (14) 
yields three possible outcomes (namely φf ≤ φm, φm < φf < φsec and φf ≥ φsec). The corresponding regions in the (k, 
c) plane are shown in Fig. 5C. If φf ≤ φm (Region I in Fig. 5C), healthy cells satisfied their maintenance demand 
from S alone throughout the dynamics, while aberrant cells exhibited sustained waste secretion. In this region, 
aberrant growth is limited by excess toxicity and aberrant take-over is only achieved if the turn-over rate k is 
large enough to ensure remediation. A different scenario is obtained when φm < φf < φsec (Region II in Fig. 5C). 
Here, although the waste secreted by aberrant cells was initially uncoupled to the metabolism of healthy cells, 
eventually φ crosses the threshold φm, a waste shuttle kicks-in and is sustained from then on. Again, the growth 
of aberrant cells is affected by waste toxicity, but its effects are now countered by a combination of healthy cell 
recycling and the turn-over rate k. Finally, if φf ≥ φsec, waste secretion and recycling are not sustained because at 
some point in the dynamics φ becomes larger than the threshold φsec. This leads to a state where aberrant growth 
can only be limited by nutrient availability. In this scenario, either the primary nutrient does not suffice to sustain 
a fully aberrant state (φf = φgr in this case), or the aberrance eventually takes over the tissue (φf = 1). In other 
words, φf = min{1, φgr}. Additionally, φsec may become negative in Region III, defining a sub-region where waste 
is never secreted (Region IIIb in Fig. 5C). On the other hand, the portion of region III where φsec > 0 (Region IIIa 
in Fig. 5C) has a transient waste secretion.
In Fig. 4A the (k, c) plane was split according to the role of waste. Confronting the two classifications one 
sees that region W+ coincides with region I as defined above, while region Sh. turns out to be composed of 
Regions II (where shuttling, once started, is sustained indefinitely) and IIIa (where waste secretion and shuttling 
are transient). Finally, region W− coincides with IIIb. The disjoint white areas of Fig. 4A where aberrant cells 
fail to expand to the entire tissue, one lying inside W− and the other inside W+, are now explicitly seen to trace 
Figure 4. Summary of results for the spatially homogeneous model. (A) Fraction φ of aberrant cells (color-
coded) as a function of the primary nutrient level in the blood (c) and of turn-over rate (k). Regions W−, Sh. 
and W+ are as in Fig. 3. The blue line marks the discontinuous transition from a healthy to a fully aberrant 
tissue at the upper separation between regions Sh. and W+. (B) Comparison between the fully spatial and 
mean-field models. We show φ versus k at fixed c = 7.5 and φ versus c at fixed k = 50 for the former (blue 
markers, obtained in many different runs) and the latter (red line). (C) Fraction of aberrant cells (φ), tissue 
level of primary nutrient (s), tissue level of waste (w), primary nutrient intake flux by healthy cells (u) and waste 
intake flux by healthy cells (v) as a function of k for low (left column) and high (right column) values of c. The 
blue arrow in top-right plot marks the discontinuous transition highlighted in (A). The values of c used in (C) 
are shown by yellow lines in (A).
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back to different causes, namely nutrient scarcity for W− and waste toxicity for W+. Additionally, the sharp 
discontinuity highlighted by the blue boundary in Fig. 4A finds a simple interpretation. On the right side of the 
edge, aberrant growth is limited by toxicity and φf < φsec. On the left side, instead, waste is transient and nutrient 
availability becomes the determining factor, i.e. φf = min{1, φgr}. The discontinuity therefore simply describes the 
transition from a state with φf < φsec to one with φf = min{1, φgr}.
The role of random fluctuations in the dynamics of the spatial model. As pointed out above, while 
the phase diagrams in Figs 3 and 4 are qualitatively very similar, a major difference derives from fluctuations in the 
spatial model. In particular, in the parameter region where waste shuttling occurs, the spatial model exhibits a bista-
ble behaviour such that random fluctuations may drive the tissue towards a fully aberrant or a fully healthy state (see 
Fig. 4A,B). Sample trajectories displaying this phenomenon are shown in Fig. 6. For the same initial conditions and 
parameters, we plot the fraction φ of aberrant cells versus time in a simulation of the mean-field model (blue line) 
and in several simulations of the spatial model (red and black lines). Trajectories where the spatial model’s outcome 
qualitatively agrees with the mean-field model are shown in black, while cases in which the spatial model diverges 
from the mean-field behaviour are shown in red. One sees that fluctuations can bring the tissue to a healthy state 
when most trajectories converge to an aberrant one (as in Fig. 6A) or vice versa (as in Fig. 6B).
Intuition about how fluctuations may lead to different outcomes can be obtained by noting that, in terms of 
the thresholds derived for the mean-field model, toxicity limits aberrant growth only if φf < φsec whereas waste 
accumulation ceases if the aberrant fraction reaches a value larger than φsec. In between, a critical value of φ 
exists beyond which waste accumulation decreases if the fraction of aberrant cells increases and aberrant growth 
becomes positive. If, by random fluctuations, the aberrant cell population overcomes this threshold, it will then 
continue to grow up to the maximum value allowed by nutrient availability (i.e. min{1, φgr}). In such a case, the 
mean-field model fails to predict aberrant dominance. Likewise, if random evolution keeps φ below φsec long 
enough, toxicity caused by waste accumulation may lead to the disappearance of aberrant cells from the tissue. 
Figure 5. Summary of thresholds found in the spatially homogeneous model. (A) Aberrant cells can sustain 
a non-zero growth rate for s > sgr (or φ < φgr) and excrete waste for s > ssec (or φ < φsec). In turn, healthy cells 
need to re-cycle the waste in order to meet their maintenance goals when s < sm (or φ > φm). As a consequence, 
aberrant and healthy cells are coupled when ssec < s < sm (or φm < φ < φsec). Note that the φ-axis (top) is reversed 
with respect to the s-axis (bottom). (B) φgr, φsec and φm as functions of k and c. (C) Phase structure in terms of 
the asymptotic aberrant fraction φf. In Region I, φf ≤ φm; in Region II, φm < φf < φsec; in Region III, φf ≥ φsec. 
The dashed line subdivides III according to whether φsec > 0 (Region IIIa) or φsec ≤ 0 (Region IIIb). The phase 
labeled W+ (resp. W−) in the phase diagram shown in Fig. 4A coincides with Region I (resp. IIIb). Region Sh. 
is instead formed by Regions II and IIIa.
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This clarifies that the equivalence between the mean-field and spatial models is not full. Remarkably, though, the 
mean qualitative behavior of the spatial model is well captured by its mean-field approximation.
Since the bistability is localized in a parameter region where waste recycling is prominent, we probed the link 
between the two occurrences. Specifically, we ran simulations of both models after disabling the shuttle by forc-
ing vhe = 0 for healthy cells. A comparison between the original and modified systems is showcased in Fig. 7. We 
zoom into the parameter region where disabling the shuttle has a stronger impact, corresponding to intermediate 
to high c and low to intermediate k (see Fig. 3). Random fluctuations resulted in bistability in the spatial model 
prominently in the region highlighted in blue in Fig. 7A, where aberrant growth is severely inhibited in absence 
of re-cycling by healthy cells (see Fig. 7B). This strongly suggests that the bistable stochastic dynamics of aberrant 
spread is enabled by the shuttling of overflow product by aberrant cells to healthy cells for recycling purposes. We 
then repeated this comparison in the homogeneous model, see Fig. 6C,D. Here silencing the shuttle only appears 
to bear a quantitative effect. As in Fig. 4A, we find a discontinuous edge (blue line) separating a region where 
growth is inhibited by toxicity from a region where growth is limited by nutrient availability. In absence of shut-
tling, the edge simply appears to shift towards slightly lower values of c (see Fig. 7D), indicating that the recycling 
of toxic overflow products by healthy cells enables aberrant growth for larger supplies of primary nutrient.
Discussion
Almost universally, cells sustaining high energy demands or fast growth undergo an overall shift in metabolic 
strategy that carries strong signatures in proteome composition and regulatory mechanisms55–57. Many expla-
nations have been put forward for the seemingly inefficient use of nutrients that occurs as cells release partially 
metabolized substances into their surrounding environment58. In some cases, exceeding protein costs prevent the 
operation of high-yield respiratory at fast growth13, 59, but this scenario does not appear to be generic even for bac-
teria60. Likewise, crowding or capacity constraints account for the onset of the inefficient phase10 but likely can’t 
be invoked universally61. The challenge of understanding the fundamental trade-offs driving metabolic strategy 
selection in different cases is therefore still largely open. In turn, though, metabolic decisions by individual cells 
can determine significant population-level effects, for instance by inducing cross-feeding interactions62, which 
then feed back into the fitness of individual cells.
Working along these lines, we have studied here how a spatially distributed population of interacting cells with 
very different energetic demands self-organizes in a shared environment coupled to a single nutrient reservoir. 
The model we define can be seen as a minimal approach to the analysis of the initial stages of the spread of an 
aberrance in a tissue. Many types of tumors generate an acidic microenvironment due to disregulated metab-
olism and lactate overflow63. Based on empirical evidence, we assume that (i) the tissue exchanges a primary 
nutrient with a reservoir that also serves as a sink for the overflow product, (ii) lactate shuttling may occur, i.e. 
non-aberrant neighbours of aberrant cells may intake lactate if the primary nutrient is insufficient to ensure their 
maintenance, (iii) the replication and death rate of aberrant cells are affected by the local level of lactate, and (iv) 
both the primary nutrient and lactate can diffuse across the tissue. From a physical viewpoint, the key assumption 
is that metabolism occurs on faster time scales than across-tissue diffusion, so that cells can effectively opti-
mize their metabolic profile while local concentrations are fixed. Besides modeling details, this is a point where 
our work departs from the approaches presented e.g. in ref. 36, where a dynamic description of metabolism is 
employed. Our simplified (in this respect) scenario allows for the study of an extended, spatially organized system 
with a large number of cells.
Many physiological aspects are however highly schematized. For instance, our representation of the blood as 
a nutrient reservoir at fixed concentration ignores variability in blood glucose levels, which have been observed 
to be significant in specific conditions64. An increase of fluctuations is thought to be generically linked to the 
approach to dynamical transitions65 and would impact the scenario discussed here. Likewise, we have employed 
a minimal representation of cellular metabolic networks that allows to focus on the organization of tissue-wide 
energy metabolism while keeping parameters to a controllable minimum. Performing a similar analysis starting 
from genome-scale models of metabolism would require a significant additional computational effort focused on 
Figure 6. Bi-stability in the spatial model. (A,B) Aberrant cell fraction (φ) plotted against time for the mean 
field model (blue line) and for several runs of the spatial model (black lines if the dynamical outcome of the 
spatial model agrees qualitatively with the spatially homogeneous model, red otherwise), for the different 
reported values of k and c. Main panels: behaviour for short times. Insets: behaviour for ling times.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 3103  | DOI:10.1038/s41598-017-03342-3
selecting thermodynamically viable flux patterns66, 67. The qualitative scenario emerging from the present study 
however is unlikely to be altered in a more complex, parameter-rich setting.
Our results are summed up in the phase portrait of Fig. 3 (similar to the outcome diagram obtained for 
cross-feeding microbial populations in ref. 36), where the asymptotic state of the tissue (in terms of the fraction 
φ of aberrant cells) is shown as a function of the primary nutrient level s and of the tissue-reservoir turn-over 
rate k. Three phases appear. In the phase labeled W− (sufficiently small c and k), the spreading dynamics of the 
Warburg-like phenotype is limited by nutrient availability and no shuttling of overflow product occurs. Upon 
increasing c and/or k one enters the Sh. region. All over this phase, the aberrant spreading dynamics is sustained 
by healthy cells re-cycling harmful overflow products. However, the long-term state of the tissue is typically 
healthy for large c and small k (in which case waste toxicity limits aberrant take-over in spite of microenviron-
mental cooperation) and aberrant for large k and small c (when a combination of efficient waste re-cycling and 
fast turn-over with the blood leads to a fully aberrant state). Finally, region W+ is found at large enough c and k. 
Here, no re-cycling takes place and the long-term state of the tissue is determined essentially by its coupling to 
the blood (healthy for slow turn-over, aberrant for fast turn-over). We have tracked the physical origin of these 
phases through a simplified, mathematically tractable version of the model whose solution ultimately relies on 
just 3 variables (the fraction of aberrant cells and the levels of primary nutrient and waste) and 3 (combinations 
of) parameters given by the thresholds in (13) or (14). The main feature escaping the solvable model is the pres-
ence of bistability, occurring in the spatial model for large c and small k. Here, the final state of the tissue can be 
strongly influenced by random fluctuations occurring during the dynamics. This phenomenon appears to be cou-
pled to the shuttling of overflow products between aberrant and healthy cells, as revealed by disabling re-cycling 
by non-aberrant cells in Fig. 7.
Stretching out the information encoded in the phase structure, our simulations suggest different qualitative 
strategies to slow down aberrant growth. At intermediate k, one may either deprive aberrant cells of primary 
nutrients by decreasing c or foster growth suppression via tissue toxification by increasing c. For higher k and 
Figure 7. Effect of shuttling in spatial and homogeneous model. Phase portraits obtained for the spatial (A,B) 
and the homogeneous (C,D) models, with enabled (A,C) and disabled (B,D) overflow product shuttling. Notice 
that the range of values of c and k are narrower with respect to those employed in Figs 3 and 4A. Outside the 
shown ranges, turning off re-cycling by healthy cells appears to bear no impact on the final state of the tissue. 
Notice that aberrant growth in the region of bistability shown in (A) is significantly reduced by silencing the 
shuttle, see (B).
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high enough c, the aberrance spread can be halted by toxicity. In this regime increasing c is the only way to lead 
the tissue back to a healthy state. Increased glucose supply in tumors is known to lead to faster acidification42, 
an effect that is usually connected to the production of lactate. Moreover, glucose infusion leads to less effi-
cient blood-tissue turn-over, probably due to enhanced viscosity68. This aspect also contributes to acidification42. 
Notice that arterial vasodilators may selectively increase perfusion in tissues, leading to a fall in their pH69. Our 
results also suggest that targeting lactate shuttling in tumors42, 70 may be effective in driving a tissue from an 
aberrant state towards a healthy state, provided k is sufficiently low and c is high, in agreement with experimental 
findings29, 71. It is however important to remark that the role of lactate in cancer is turning out to be much broader 
than the aspects on which we focus here, especially in connection to its interaction with the immune system72. 
In this sense, our model is more relevant to the understanding of early lesions consisting of a few aberrant cells, 
which are effectively invisible to the immune system due to their small size.
Methods
Choice of parameters. Our choice of parameters was guided by the example of the glucose-lactate pair (for 
primary nutrient and overflow product, respectively) in cancer growth.
The ATP yields appearing in (1) were chosen following the simple glycolytic models of refs 28, 50, i.e. Yu = 1 
and Yr = 19 (both giving moles of ATP output per mole of S imported). The ATP demand related to maintenance 
for mammalian cells is usually reported to be around73 em = 10 pmol/day/h3, where .h 0 01mm denotes the 
typical linear dimension of a cell (see also below). The parameters λmax and KE in (6) were fitted to agree with the 
approximate linear relation between e − em and the growth rate at low energy production rates (with a proportion-
ality constant close to 10 pmol/cell)73 and with the observed maximum growth rate of mammalian cells (close to 
3 day−1, see ref. 74), obtaining λmax = 2 day−1 and KE = 20 pmol/day/h3.
The most commonly expressed glucose transporter in mammalian cells is GLUT1, with a reported affinity of 
1 mM75, 76. The average physiological concentration of glucose in the blood is around 5 mM. Assuming that the 
uptake of healthy cells follows a Michaelis-Menten law and that this concentration is enough to sustain the main-
tenance demand, we can solve for umax in the equation um = uMM(s) to obtain a value of umax = 0.5 pmol/day/h3. 
We re-defined the glucose to lactate stoichiometric ratio to one by doubling glucose levels and setting Ks = 2 mM, 
umax = 1 pmol/day/h3. To model the up-regulation of glucose transporters in growth-optimizing aberrant cells we 
use α = 100 in (4). With the example of lactate in mind, with a measured Michaelis constant ranging between 
1 mM and 10 mM, we set Kw = 5 mM, while the maximum uptake of this metabolite has been reported77–79 around 
vmax = 100 pmol/day/h3.
Measured values of the glucose diffusion coefficient in tissue span values between 10−6 cm2/sec and 10−5 cm2/
sec, depending on the tissue and measurement technique80–82. We adopted an intermediate common value of the 
diffusion coefficient for substrate and waste, of 1.5 × 10−6 cm2/sec. Cells in the 2-dimensional grid were assumed 
to be a distance h apart that reflects the number of cells per unit area in flat tissues. This value varies widely 
across different tissues83, 84, and we set it to 104 cells/mm2, which implies a typical distance h between cells around 
0.01 mm. Coupling this to the coefficients of the discretized Laplacian operator in the 2-dimensional grid (d/h2), 
we obtain the value 0.06 sec−1 for the effective diffusion constants DS and DW.
The inhibitory effects of waste on growth are again modeled after lactate. Quantitative expressions have been 
obtained from in vitro studies. We use the values Kinh = 8 mM, Ktox = 15 mM and σmax = 2 day−1 from ref. 53, but 
see also refs 85–87.
We assume that cells have a maximum capacity to fully oxidize the precursor P arising e.g. from a limitation in 
the proteome fraction available for enzyme production12 or by limited mitochondrial efficiency15. Following28, 50, 
we set rmax = 6.48 pmol/day/cell.
Finally, metabolite levels are measured in units of Ktox (so that Ktox = 1), time is measured in units of 1/σmax, 
and fluxes are re-scaled by Ktoxσmax. The detailed definition of non-dimensional parameters is provided in the 
Supporting Text.
Note that, with these choices, the standard values of c ranging from hypoglycaemic to hyperglycaemic con-
ditions covers about an order of magnitude in the central part of the vertical axis of Figs 3 and 4A. Therefore the 
overall range of values for c and k over which we characterize both the spatial model and the simplified one is con-
siderably broader. Note however that the physiological range contains each of the different phases and sub-phases 
that we characterize.
Simulation details. Numerical simulations of the lattice model were carried out in Julia88. The script is 
available from Github (https://github.com/cossio/aberr). To speed up simulations, we exploited the fact that the 
spatial distribution of metabolite levels equilibrates fast compared to cell dynamics. Specifically, at each step, we 
checked whether metabolite levels have equilibrated, and advanced cell dynamics to the next division/death event 
(following the Gillespie algorithm89) whenever an equilibrium had been achieved. The asymptotic fraction of 
aberrant cells in the mean field model was computed by simulating the model’s ODEs for a very long time using 
the ‘NSolve’ routine from Mathematica.
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